Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 07 1995, 1769-1774, Vol 33, No. 7
WJ Van Wamel, AC Fluit, T Wadstrom, H van Dijk, J Verhoef and CM Vandenbroucke- Grauls
Forty strains of methicillin-resistant Staphylococcus aureus (MRSA) were
divided on the basis of their epidemiologic behavior into two subgroups,
sporadic MRSA (SMRSA) and epidemic MRSA (EMRSA) strains. The strains were
examined for binding of 125I-labelled fibronectin, vitronectin, collagen,
Fc fragments of immunoglobulin G, and fibrinogen. A significant difference
between EMRSA and SMRSA strains was found for binding of 125I-labelled
fibrinogen and for Fc fragments of immunoglobulin G, (P < 0.05). No
significant difference in the binding of 125I-labelled fibronectin and
collagen was found between EMRSA and SMRSA strains. The binding of
125I-labelled vitronectin to MRSA strains was found to be aspecific.
Capsular serotypes of the strains were determined with monoclonal
antibodies against capsular types 5 and 8. Strains could be divided into
the following four groups: types 5, 8, and 5/8 and nontypeable. More
nontypeable strains were found in the EMRSA group (66.6%). Significantly
more EMRSA strains (79%) than SMRSA strains (44%) produced alpha-toxin (P
< 0.025). Logistic regression analysis using a combination of the
parameters 125I- labelled immunoglobulin G binding, capsular type, and
alpha-toxin production predicted the epidemic character with a sensitivity
of 83% and a specificity of 75%.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Phenotypic characterization of epidemic versus sporadic strains of methicillin-resistant Staphylococcus aureus
Eijkman-Winkler Institute for Medical and Clinical Microbiology, Utrecht University, The Netherlands.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|